Establishing the diagnosis neurofibromatosis type 1: A rare case


Published: 1 April 2019
Abstract Views: 1071
PDF: 508
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Dyatiara Devy Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga / Dr.Soetomo General Hospital, Surabaya, Indonesia.
  • D. Damayanti Departement of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga / Dr.Soetomo General Hospital, Surabaya, Indonesia.

Neurofibromatosis type 1 (NF1) or Von Recklinghausen's disease is a dominantly inherited genetic, multisystem disorder. Individuals with neurofibromatosis type 1 are prone to develop benign and malignant tumors of the CNS and peripheral nervous system, in addition to malignant diseases affecting other parts of the body. About 50% of individuals with neurofibromatosis type 1 have no family history of the disease and the disease is due to de novo (spontaneous) mutations. Early diagnosis is challenging because of its extremely variable characteristics. Some individuals may be mildly affected showing minimal signs, whereas others are severely afflicted. Individuals with NF-1 are best cared for within a multidisciplinary clinic, which has access to a wide range of subspecialists. The dermatologist has a role not only in the diagnosis of NF1 and differentiating it from other similar disorders, but also in the recognition of rare associated skin manifestations.


Devy, D., & Damayanti, D. (2019). Establishing the diagnosis neurofibromatosis type 1: A rare case. Dermatology Reports, 11(s1). https://doi.org/10.4081/dr.2019.8092

Downloads

Download data is not yet available.

Citations